A new report predicts the United States will “reach a tipping point on vaccine enthusiasm” in just a few weeks, meaning supply will outstrip demand. President Joe Biden unveils a new stimulus plan to incentivize vaccinations. This one would offer tax credits to small businesses that give employees paid time off to get their shots….
Does Natural Immunity Earn Some Freedom?
Millions have rolled up their sleeves to take the COVID-19 vaccination because the jab promises protection against the notorious pathogen. However, millions more remain hesitant. Now, officials are pushing a new incentive: freedom. A growing number of universities now require that students get vaccinated before they return to campus. Airlines and workplaces are devising apps…
Johnson & Johnson COVID-19 Vaccine Effective, Even Against Variants: Trial
Johnson & Johnson’s COVID-19 vaccine helps protect against moderate to severe illness, newly published clinical trial results show. The jab was 67 percent effective in protecting against moderate to severe COVID-19, the disease caused by the CCP (Chinese Communist Party) virus, at 14 days after vaccination, according to research published in the New England Journal of…
22 in Chicago Nursing Homes Tested Positive for COVID-19 After Vaccination
Twenty-two people in skilled nursing homes in Chicago have tested positive for COVID-19 two or more weeks after being fully vaccinated against the virus that causes it, officials disclosed on Wednesday. Out of 627 people with confirmed infections of the CCP (Chinese Communist Party) virus in skilled nursing facilities (SNF) in the Illinois city, 12 residents and 10…
Pfizer COVID-19 Vaccine May Trigger Shingles in Certain Patients: Study
The mRNA Pfizer/BioNTech COVID-19 vaccine may trigger herpes zoster—or shingles—in certain patients after just one dose, a new study suggests.
J&J to Cooperate in Study of Rare Blood Clots Linked to CCP Virus Vaccine
Johnson & Johnson has agreed to work with a German scientist studying rare blood clots linked to its vaccine for the CCP virus, which causes the disease COVID-19. Andreas Greinacher, a transfusion medicine expert at Greifswald University, was already studying blood clots in patients who received the AstraZeneca CCP (Chinese Communist Party) virus vaccine. Johnson & Johnson…
J&J Reports $100 Million in Vaccine Sales as Results Top Forecasts
April 20, 2021
admin
AMERICABusinessCCP VirusCompaniesforecastsHealth EducationJohnson JohnsonmillionsalesUSUS NewsVaccineVaccines & SafetyWorld
0 Comment
Johnson & Johnson beat expectations for quarterly earnings and raised its dividend payouts to shareholders on Tuesday, while reporting $100 million in sales of its COVID-19 vaccine, whose use was paused by U.S. regulators last week. The company, which has previously said the vaccine will be available on a not-for-profit basis until the end of…
EU Regulator Finds ‘Possible Link’ Between J&J Vaccine and Blood Clots
April 20, 2021
admin
Astrazenecablood clotsCCP VirusCOVID-19EuropeEuropean Medicines AgencyEuropean UnionJanssenVaccineVaccines & SafetyWorld
0 Comment
The European Union’s medicines regulator said on Tuesday that there is a “possible link” between Johnson & Johnson’s COVID-19 vaccine and blood clots, but said its “overall benefit-risk remains positive.” At a meeting on Tuesday, the safety committee of the European Medicines Agency (EMA) concluded that a warning about unusual blood clots should be added…
WHO Panel Recommends Against Vaccine Passports
A World Health Organization (WHO) panel has recommended against requiring proof of vaccination against COVID-19 to travel to other countries. In a statement Monday, the WHO’s Emergency Committee recommended to Director-General Tedros Adhanom Ghebreyesus to avoid mandates for people to prove they are vaccinated before going into other countries. “Do not require proof of vaccination as…
FDA Orders Johnson & Johnson Contractor to Pause Vaccine Production at Plant With Prior Contamination Issue
April 19, 2021
admin
AMERICABusinessCCP VirusCompaniesHealth EducationinspectionJohnson JohnsonUSUS NewsVaccineVaccines & Safety
0 Comment
A contractor that makes ingredients for Johnson & Johnson’s COVID-19 vaccine said in a filing Monday that federal regulators ordered a stoppage to its production of the drug substance for the duration of an inspection at a Maryland facility that was previously plagued with a contamination issue. Emergent BioSolutions, which has a contract to manufacture…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta